Search



Research Discipline: Cancer Biology

Swami, Nathan

6/17/2025

Summary: Nano-electromagnetics (NEMS)--Signaling at the nano/bio interface: The measurement, analysis and propagation of electrical, magnetic and optical signals with nanoscale spatial resolution is of interest within biomolecular sensing, morphogenesis, tissue regeneration,…

Tang, Shangming

6/17/2025

The Tang laboratory applies a wide range of approaches such as live-cell imaging, single-cell genomics, and biochemistry to study the mechanisms of complex genome rearrangements in cancers, developmental disorders, and…

Tao, Jianguo

6/17/2025

Taylor, Justin J

6/17/2025

The Taylor lab is focused on unlocking the potential of B cells to protect against infection, cancer, and other diseases where these cells could benefit human health. B cells are…

Trinh, Bon Q

6/17/2025

Myeloid cells, including granulocytes and macrophages, play a crucial role in the body's de­fense against infections. Abnormalities in their functions and maturation cause various diseases. At the Trinh laboratory, we…

Vande Pol, Scott B.

6/17/2025

Papillomaviruses cause the most common lethal malignancy in women world-wide: cervical cancer. Our laboratory studies the actions of the papillomavirus E6 oncoprotein. By identifying host proteins that associate with E6,…

Wang, Qiwei

6/17/2025

Research Projects Targeting the intersection of cancer cell-intrinsic signaling and innate immunity  The innate immune cells are often suppressed within the tumor microenvironment or co-opted to promote tumor progression and metastasis. Our…

Wang, Yuh-Hwa

6/17/2025

Our research focus is to understand the structure and function of unusual DNA sequences in living cells, and how these sequences cause genome instability and lead to human diseases. Human…

Weaver, Tyler M.

6/17/2025

The genomic DNA of eukaryotes is packaged into chromatin through a fundamental repeating unit known as the nucleosome. In this chromatin environment, our genomic DNA is constantly exposed to a…

Witt, Russell Gardner

6/17/2025

Despite advancements in melanoma treatment with immune checkpoint blockade (ICB) and BRAF-targeted therapy, 40-65% of metastatic melanoma patients do not survive beyond five years. An observed 'obesity paradox' shows improved…